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Preliminary and Short Report
THE RELATION OF HEXOSE PHOSPHATES TO THE EPIDERMAL
PHOSPHOFRTJCTOKINASE VELOCITIES IN PSORIASIS*
J. HASEGAWA, M.D.
The enzyme, phosphofructokinase, from the
affected epidermis of psoriatic patients behaves in
a peculiar manner toward the hexose phosphate
isomers, fructose-6-phosphate and glucose-6-phos..
phate (1). Many psoriatic epidermal extracts with
an excess of phosphohexose isomerase exhibit a
significantly slower phosphofructokinase velocity
with glucose-6-phosphate than fructose-6-phos-
phate. This velocity difference has been observed
infrequently in non-psoriatic dermatoses. It ap-
pears progressively and almost universally in au-
topsy and surgical tissues which have been stored
in liquid nitrogen or at —25°C (unpublished data).
Theoretically this peculiar phenomenon should
not occur. If the enzyme extract contains phos-
phohexose isomerase, it is reasonable to expect
that the actual substrate during the assay of
phosphofructokinase is an equilibrium mixture of
glucose-6-phosphate and fructose-6-phosphate, ir-
respective of the starting compound. Any excess
of either hexose phosphate over the equilibrium
concentration will be converted into its structural
isomer by the enzyme, phosphohexose isomerase,
since this enzyme catalyzes the reaction in either
direction. Therefore the phosphofructokinase ve-
locity of crude enzyme extracts should be essen-
tially the same with either glucose-6-phosphate or
fructose-6-phosphate.
However, if one assumes that glucose-6-phos-
phate depresses the activity of the psoriatic phos-
phofructokinase, the velocity will depend upon
two factors: 1) the ratio of phosphohexose isom-
erase to phosphofructokinase and 2) the average
concentration of glucose-6-phosphate as well as
fructose-6-phosphate during the period of assay.
From a consideration of the kinetics of such an
assumption it is possible to predict the approxi-
mate behavior of enzymes which are depressed as
well as those unaffected by glucose-6-phosphate
under varying enzyme ratios (Fig. 1). The purpose
of this preliminary study was to compare the ob-
served data with the predicted curves when the
ratio of phosphohexose isomerase to phosphofruc-
tokinase was determined.
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MATERIAL AND METHOD
Nineteen patients with psoriasis and 15 non-
psoriatic patients were studied. Following Frigi-
derm spray locally the epidermal specimens were
obtained in a single stroke with a Castroviejo
keratome set to cut at a thickness of 0.1 mm. The
specimens were divided into two portions and
frozen in liquid nitrogen. One portion was homog..
enized in 0.01 M Na2HPO4 solution in the pro-
portion of 50 mg wet weight of tissue/ml. The
homogenate was centrifuged at 4100 RPM at
3° C. in nitrogen atmosphere for 10 minutes, and
the supernate was used as the source of enzyme.
The assays with this portion were started within
2 hours and completed within 5 hours from the
time of biopsy removal. The second portion was
sectioned in a cryostat at 10 micron thickness,
—20° C. Every 50th section was placed on a glass
slide, fixed in 10% formalin in 90% ethanol, and
stained with hematoxylin and eosin for histologi-
cal control. The remaining sections were wrapped
in aluminum foil and placed in a freeze-dry ap-
paratus (Thermovac) at —40° C in vacuum. At
the end of 18—20 hours the electronic gauge regis-
tered below 8 microns Hg pressure. The tissues
were removed, weighed, suspended in 0.01 M
Na2HPO4 in the proportion of 15 mg tissue/ml. A
homogenate was prepared and treated as de-
scribed above.
The phosphofructokinase velocity was meas-
ured by the method of Racker (2). The phospho-
hexose isomerase velocity was measured in the
direction of fructose-6-phosphate to glucose-6-
phosphate in the presence of an excess of glucose-
6-phosphate dehydrogenase (3). For each specimen
two ratios were calculated:
(A) Phosphofructokinase velocity with glucose-6-
phosphate/Phosphofructokinase velocity with
fructose-6-phosphate and
(B) Phosphohexose isomerase velocity with fruc-
tose-6-phosphate/Phosphofructokinase veloc-
ity with fructose-6-phosphate.
Since the interpretation of the first ratio depends
upon the second, they are plotted as coordinates
on a graph (Fig. 2).
RESULTS
Between (phosphohexose isomerase/phospho-
fructokinase) of one and two, a curved line drawn
from 0.4 to 0.65 on the ordinate separated the
psoriatic from the non-psoriatic values. At ratios
greater than two, the (phosphofructokinase with
glucose-6-phosphate/phosphofructokinase with
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fructose—6-phosphate) values below 0.65 were al-
most exclusively psoriasis. Above 0.65 there was
intermingling of psoriatic and non-psoriatic values.
There were no ratios of (phosphohexose isomerase/
phosphofructokinase) below 0.8 for extracts of
affected epidermis. The observed data are com-
patible with the predicted curves. At very large
(phosphohexose isomerase/phosphofruetokinase)
ratios the velocity differences for phosphofructo-
kinase between glucose-6-phosphate and fructose-
6-phosphate become indistinguishable between
psoriatic and non-psoriatic extracts. The separa-
tion of psoriatic and non-psoriatic values theoreti-
cally should be optimal at enzyme ratios between
one and two. In practice, however, this proves to
be the most treacherous area for interpretation
because the slope of the dividing line requires an
extremely accurate estimate of the phosphohexose
isomerase velocity.
COMMENTS
The peculiar behavior of the psoriatic epidermal
phosphofructokinase is consistent with the as-
sumption that glucose-6-phosphate depresses the
phosphofructokinase activity. Recently it has
been stated that this was unlikely because there
was no change in velocity when glucose-6-phos-
phate was added to fructose-6-phosphate in the
assay of phosphofructokinase velocity with homo-
Fzo. 1. PFK (G-6-P)—phosphofructokinase ve-
locity with glucose-6-phosphate, 1.0 mM concen-
tration• PFK (F-6-P)—phosphofructokinase veloc-
ity witi fructose-6-phosphate, 1.0 mM concentra-
tion; PHI—phosphohexose isomerase velocity with
fructose-6-phosphate; PFK—phosphofructokinase
velocity with fructose-6-phosphate; Bold line—
predicted behavior of enzyme extracts unaffected
by glucose-6-phosphate; Double line—predicted
behavior of enzyme extracts in which phosphofruc-
tokinase is depressed by glucose-6-phosphate;
Dotted line—approximate lower limit of enzyme
extracts unaffected by glucose-6-phosphate.
0
.
0 0
/6
S
0
0 0
I I I
0 1.0 2.0 3.0 ',3.4
PHI
P1K
FIG. 2. PFK (G-6-P)—-phosphofructokinase ve-
locity with glucose-6-phosphate, 03—1.0 mMcon-
centration; PFK (F-6-P)—phosphofructokinase
velocity with fructose-6-phosphate, 0.3—1.0 mM
concentration; PHI—phosphohexose isomerase ve-
locity with fructose-6-phosphate; PFK—phospho-
fructokinase velocity with fructose-6-phosphate;
Dotted line—approximate lower limit of enzyme
extracts of epidermis obtained from non-psoriatic
patients; Solid dots—enzyme extracts from the af-
fected epidermis of non-psoriatic patients; Open
dots—enzyme extracts from the affected epidermis
of psoriatic patients.
genates of psoriatic tissue (4). In the presence of
phosphohexose isomerase the actual substrate is
a mixture of glucose-S-phosphate and fructose-6-
phosphate whether glucose-6-phosphate is added
or not, and no conclusions are warranted with
experiments of this type.
Until it becomes possible to inactivate phos-
phohexose isomerase selectively in the psoriatic
epidermal extracts, a significant difference in the
phosphofructokinase velocity of inflamed epidermis
between fructose-S-phosphate and glucose-6-phos-.
phate as the starting compound may be interpreted
tentatively as an indication of glucose-S-phosphate
depression of phosphofructokinase activity (5).
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